Home › Funds › Point72 Asset Management › STRO
Point72 Asset Management position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)237.83K sh
Reported value held$7.90M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 375.00K | $7.08M | New |
| Q3 2022 | 711.00K | $3.95M | New |
| Q4 2022 | 790.60K | $6.39M | Add |
| Q2 2023 | 209.00K | $971.87K | New |
| Q3 2023 | 533.15K | $1.85M | Add |
| Q4 2023 | 285.70K | $1.23M | Reduce |
| Q1 2024 | 260.70K | $1.47M | Reduce |
| Q2 2024 | 4.45M | $13.03M | Add |
| Q3 2024 | 3.00M | $10.37M | Reduce |
| Q4 2024 | 2.20M | $4.04M | Reduce |
| Q4 2025 | 179.09K | $2.07M | New |
| Q1 2026 | 692.11K | $17.24M | Add |
| Q2 2026 | 237.83K | $7.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026